The Centers for Disease Control and Prevention (CDC) recently updated its routine immunization schedule by including the COVID-19 vaccine for both children and adults. Although the CDC does not have the power to establish requirements, its immunization schedule serves as a source of guidance for state and local public health officials who determine which vaccines are mandatory for school attendance. Furthermore, the schedule is used as the foundation for vaccine recommendations made by most medical practitioners.
However, not everyone is in support of this move. Mary Holland, the president and general counsel of Children’s Health Defense, stated: “Given all we have learned about the dangers and ineffectiveness of COVID-19 shots over the last two years, it is horrifying to see the CDC now recommend this as a routine shot to children. Although it is unsurprising given the agency capture, it is nonetheless tragic.”
The decision by the CDC formalizes the recommendation made by its vaccine advisory committee, which voted unanimously on October 20, 2022, to include COVID-19 vaccines for children as young as 6 months old on the Child and Adolescent Immunization Schedule. According to the new guidelines, the CDC suggests that healthy children aged 6 months to 11 years receive a two-dose series of mRNA Moderna or Pfizer-BioNTech monovalent COVID-19 vaccine, followed by a bivalent booster. The CDC recommends that healthy individuals aged 12 and above receive two doses of either the Moderna, Pfizer, or Novavax vaccine, followed by a bivalent booster.
All COVID-19 vaccines administered to individuals under 18 in the United States are classified as Emergency Use Authorized (EUA) products. While the Comirnaty COVID-19 vaccine from Pfizer was granted full approval by the U.S. Food and Drug Administration for individuals aged 12 and above, it is not available in the United States, meaning that all children who receive the Pfizer vaccine are getting a EUA product.
During a recent congressional hearing on the Biden administration’s COVID-19 response, Rep. Dan Crenshaw asked CDC Director Dr. Rochelle Walensky why the CDC deviated from its norm by including a EUA vaccine in the childhood immunization schedule for a disease that poses little risk to children and for which the vaccine has numerous potential side effects without preventing transmission. Dr. Walensky explained: “The reason the Advisory Committee on Immunization Practices recommended the CDC put the COVID-19 vaccine on the pediatric schedule was only that it was the only way it could be covered in our ‘Vaccines for Children program. It was the only way that our under-insured children would have access to the vaccines… That was the reason to put it there.”
The U.S. Centers for Disease Control and Prevention (CDC) is under scrutiny for its updated childhood vaccination schedule, which now includes the COVID-19 vaccine. Critics argue that data collected by the CDC’s own Vaccine Adverse Event Reporting System (VAERS) and other sources show serious health risks associated with COVID-19 vaccination for children. Furthermore, the vaccine has not been proven effective or safe for children, with the benefits being “minuscule” compared to the “known and serious” risks, including the risk of potentially fatal heart damage, as acknowledged by the Food and Drug Administration (FDA).
Despite these concerns, the CDC’s childhood vaccination schedule seeks to “normalize” the COVID-19 vaccine and promote it as a routine vaccination, just like any other vaccine. However, with only 12% of children ages 6 months to 4 years having received one dose of the vaccine, and only 58% of children ages 12 to 17 and 32% of children ages 5 to 11 having received two doses, there is still a long way to go before the vaccine becomes widely adopted.
Worryingly, the revisions to the childhood vaccination schedule protect vaccine makers from liability for injuries or deaths caused by COVID-19 vaccines, which are covered by the Countermeasures Injury Compensation Program (CICP). To date, only 19 claims related to COVID-19 have been found eligible for compensation, with no compensation paid as yet. In comparison, the National Vaccine Injury Compensation Program (NVICP) has received nearly 12,000 claims since 2010 but has only compensated 30.
Moreover, VAERS data on vaccine injuries, updated on February 2nd for children 6 months to 5 years old who received the COVID-19 vaccine, showed reports of 5,737 adverse events, including 244 cases rated as serious and 14 reported deaths. For 5- to 11-year-olds, there were 16,910 reports of adverse events, including 805 rated as serious and 33 reported deaths. Despite these numbers, VAERS has been shown to report only 1% of actual vaccine adverse events, meaning the actual number of adverse events could be much higher.
At a recent congressional hearing, lawmakers expressed concerns about the lack of public trust in public health agencies, with 40% of the public reportedly not trusting public health agencies to handle the next public health emergency. Additionally, there was a decline in vaccination rates for all vaccines on the childhood schedule, dropping from 95% to 93% over the last two years, with hundreds of thousands of parents opting not to comply with the childhood vaccination schedule.
In conclusion, the CDC’s updated childhood vaccination schedule, including the COVID-19 vaccine, raises serious concerns about the safety and efficacy of the vaccine for children. As a result, it could well be the beginning of the end for Big Pharma’s reign over the nation’s children, as parents resist and question the entire childhood vaccine schedule.